explore -WSS

explore

author：explore 2025-10-02 10:48:49 - browse：8481

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： White House drug shortage group privately met with industry

WSS

Readout Newsletter: XBI biotech index, Akero Therapeutics

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

The pink breast cancer awareness ribbon needs a redesign

Nearly two

What the cancer research community can learn from the Covid response

Senate panel to vote on hospitals, PBMs, prisoner care

explore

explore

focus

Jerome Adams on the need for new antivirals for Covid

A cyberattack has disrupted hospitals and health care in several states

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What the cancer research community can learn from the Covid response

Anesthesiologist group: stop taking Ozempic before surgery

Diversifying clinical trials isn't enough to close racial gaps: study

Walensky prepares to leave CDC — and Congress — behind

Biden's order seeks to regulate AI risk without stifling innovation

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: New research from Sanofi, Regeneron, etc.

entertainment

What the cancer research community can learn from the Covid response

Stem cell clinics for heart failure: buyer be wary

Medtronic CEO on promising devices for diabetes, hypertension

WHO may add ‘noma' to its list of neglected tropical diseases

Physician subsidies by hospitals soar in wake of No Surprises Act

Influencer to be charged after chaos erupts in New York City's Union Square

focus

entertainment

focus

explore